Health Unchained

Eleanor Davies is the Head of DeSci at the Sei Foundation. Eleanor previously helped launch VitaDAO, the first tokenized longevity venture studio, she served as Operating Partner at Cerebrum DAO, and was COO at Convexity Labs (previously known as LabDAO). With deep experience bridging web3, biotech, and healthcare, Eleanor shared her unique insights with our community. We talk about the Sei ecosystem and the $65M Sapien Captial fund intended for accelerating DeSci projects. Host Ray Dogum and Eleanor Davies talk about the future of decentralized science (DeSci) and its role in healthcare. The conversation covers the structure and goals of the Sei Foundation's $65 million Sapien Capital Fund, which aims to accelerate DeSci projects, and the unique advantages of the Sei blockchain network. Eleanor shares insights on the potential of DeSci to bridge the innovation gap in biotech, streamline research funding, and enhance data interoperability in healthcare. The episode also touches upon the future prospects of DeSci, the importance of creating frictionless capital for research, and how the new U.S. administration's stance on crypto could benefit the industry. Eleanor wraps up by discussing her interest in running half marathons, her favorite conferences, and influential books. Guest Bio Eleanor Davies has held a series of impactful roles across biotech, venture, and Web3. She was an Operating Partner at Cerebrum DAO and served as a Dealflow Steward (~Principal) and core founding member of VitaDAO, where she launched the first tokenized longevity venture studio, scaling a community of 700 longevity biotech professionals and designing a pioneering crypto/tradfi biotech spinout model. Prior to that, she was a founding team member and Chief Operating Officer at Convexity Labs (previously known as LabDAO). At the On Deck ODX Fund, she supported a $100M capital raise and led capital deployment and portfolio management at the Silicon Valley-based accelerator. Earlier in her career, she worked at the Marwood Group, a healthcare and biotech consultancy. Connect with Eleanor: LinkedIn X Timestamps 00:00 Intro 01:26 Meet Eleanor Davies 02:20 Eleanor's Journey into DeSci 06:17 The Sei Ecosystem and $65 Million Sapien Capital Fund 14:11 DeSci Challenges and Opportunities 15:13 The Role of AI in DeSci 23:29 Future Potential of DeSci 26:01 Personal Insights and Recommendations 31:12 Takeaways Mentioned Resources Sei Foundation website Blog - What-is-desci-v2-and-why-does-it-matter Ep. 124 - Cureledgers-role-in-the-new-era-of-health-data-sharing-with-david-stefanich-nina-kilbride-dr-suren-movsisyan/ Ep. 104 - Decentralizing-womens-reproductive-health-with-laura-minquini-co-founder-of-athenadao/ Network school Favorite books - Atlas Shrugged & The Fountainhead by Ayn Rand Health Unchained Links Supercast – Sign up for early access to unedited video interviews and transcripts Website Telegram LinkedIn X Health Unchained is a leading Healthcare Technology Podcast on the web - Check us out on Feedspot

Laura Epstein, CEO and founder of Pulse Charter Connect, along with Chris Tyler, Pulse's Chief Technology Officer, join host Ray Dogum in an episode you won’t want to put on ice. They dive into their backgrounds and share how their company is revolutionizing organ transportation logistics to save time—and lives. Pulse Charter Connect (PCC) digitizes an antiquated logistics system currently used by transplant centers. We facilitate faster, safer, and more efficient transportation for organs and surgical teams, resulting in more organs transplanted and more lives saved. Additionally, the data collected from our software will empower the transplant community to further improve upon their current operations. Ultimately, with AI, we anticipate more informed, optimized decisions. Guest Bios Laura Epstein (CEO & Founder) Laura graduated from the University of Chicago Booth School of Business with her Masters in Business Administration with Honors in 2022. She also holds a Bachelors Degree in Aerospace Engineering from the University of Virginia. Prior to returning to school, Laura worked as a Systems Engineer specializing in Risk Management for the Federal Aviation Administration. Most notably, she led 200 risk management efforts impacting programs worth $1.68B per annum. She also holds her Private Pilot License. In her free time, Laura likes to fly, play with her pet cat Moocka and dog Thea, bake, and kickbox. Chris Tyler (Chief Technology Officer) Chris is an experienced software and SaaS product leader. His background includes over 30 years of experience in technology including 16 with IBM and 8 years with AT&T with a wide array of technical roles. He has a deep background in data and analytics. In his free time, Chris volunteers as the Chief Analytics Officer for the ALS Never Surrender Foundation and spends as much time as he can outdoors with his family. Timestamps 00:00 Intro 01:33 Meet the Guests: Laura Epstein and Chris Tyler 04:14 The Problem with Organ Transportation 05:13 The Complex Logistics of Organ Transplants 09:22 Innovative Solutions and Technology 12:13 Dynamic Pricing and Decentralization 14:40 Ensuring Security and Compliance 16:49 Future Plans and Industry Insights 34:12 Final Thoughts Mentioned Resources Pulse Charter Connect website Pulse Charter LinkedIn Ep. 31 with Anthony Begando (CEO of ProCredEx) Guest recommended books: My Glory Was That I Had Such Friends by Amy Silverstein Demonstrating to Win! by Robert Riefstahl & The Bible Health Unchained Links Supercast – Sign up to access premium content Website Telegram LinkedIn X Health Unchained is the Top #11 of 100 Healthcare Technology Podcasts on the web - Check us out on Feedspot

Tristan Roberts, founder of Dog Years DAO, a decentralized autonomous organization focused on improving canine longevity. They discuss the potential of using blockchain technology to manage decentralized trials and gather data more effectively. Tristan shares his journey from cognitive neuroscience to biohacking and gene therapy, detailing his experiences with HIV gene therapy and how it led to the creation of Minicircle. The conversation covers the science behind follistatin, a protein that may extend the lifespan of dogs by reducing inflammation and preventing muscle breakdown. Tristan explains the proposed methodology for the Dog Years DAO experiment, emphasizing the importance of acquiring reliable data through a system of deposits and incentives for participants. The episode also explores the ethical challenges and potential of decentralized clinical trials in the broader context of healthcare innovation. Health Unchained is the Top #15 of 100 Healthcare Technology Podcasts on the web - Check us out on Feedspot Timestamps 00:00 Intro 01:31 Guest Introduction: Tristan Roberts 02:16 Tristan's Journey into Gene Therapy 04:18 Gene Therapy for HIV 06:42 Canine Longevity and Gene Therapy 13:11 The Concept of Dog Year's DAO 18:58 Challenges and Future of Decentralized Trials 30:44 Closing Thoughts Guests Links Tristan Roberts website LinkedIn X Mentioned Resources Dog Years DAO website Dog Years DAO TG group Research Collective Telegram Group Longevity Events https://www.infinita.city/ https://www.vitalistbay.com/ https://edgecity.live/ https://www.bbc.com/news/world-us-canada-41990981 https://www.businesswire.com/news/home/20231127326868/en/FDA-Agrees-Loyal-Data-Supports-Reasonable-Expectation-of-Effectiveness-for-Large-Dog-Lifespan-Extension Health Unchained Links Supercast – Sign up to access premium content Website Telegram LinkedIn X

David Stefanich, Nina Kilbride, and Dr. Sarin Movsisyan from CureLedger join host Ray Dogum to discuss their upcoming token launch. The discussion centers on CureLedger, an initiative aimed at transforming the decentralized science (DeSci) landscape through blockchain and Web3 technologies. David speaks about Rymedi’s foundational software for Clemson University's COVID-19 testing and their evolution into CureLedger. Nina introduces her vast experience as a commercial litigation attorney and how AI and verifiable data ignited her interest in Web3. Suren emphasizes the importance of blockchain for multi-jurisdictional compliance and data security. The CureLedger team explores its unique Layer 1 protocol, emphasis on data sovereignty, and the creation of a verifiable health data marketplace. They also touch on tokenomics, community incentives, and upcoming events like the ETH Denver announcement. Health Unchained is the Top #15 of 100 Healthcare Technology Podcasts on the web - Check us out on Feedspot Timestamps 00:00 Intro 01:59 David Stefanich's Journey and CureLedger 03:18 Nina Kilbride's Background 06:09 Blockchain's Impact on Healthcare 08:33 Challenges and Solutions in Data Sharing 10:34 CureLedger's Unique Architecture 22:27 Patient Data Sovereignty and Future Prospects 32:42 Data Marts and Regulatory Compliance 34:41 Tokenomics of Cure Ledger 37:31 Target Communities and Use Cases 40:49 Smart Contracts and Data Consent 43:15 Challenges and Future Plans 58:10 Follow Cure Ledger's Journey Guests LinkedIn Profiles David Stefanich Nina Kilbride Dr. Suren Movsisyan Mentioned Resources CureLedger website CureLedger Whitepaper CureLedger LinkedIn CureLedger Telegram Channel Ep. 73: Multi-party Trust with Rymedi - David Stefanich and Dr. Jason Cross Partnering with Good Pharma (Ep. 100 with Savva Kerdemelidis) Health Unchained Links Supercast – Sign up to access premium content Website Telegram LinkedIn X

Privacy. Period.  Anna Hall is the founder and CEO of Embody Space, a menstrual cycle tracking and wellness app with 50k+ users, that prioritizes data privacy through local encryption and open-source technology. Anna shares her journey from an educator to a startup founder, driven by her own diagnosis of PMDD and the need for secure menstrual health data management post-Roe v. Wade. The discussion delves into the importance of data privacy, the risks of menstrual data being used for prosecuting abortions, and the role of technology in safeguarding personal information. Anna highlights the innovative technology stack of Embody Space, future plans for paid versions offering cycle-syncing content and encrypted backups, and potential integrations with Web3. The episode also explores the decentralization of social platforms for women's health support, the challenge of aligning with HIPAA regulations, and strategies for navigating diverse state laws regarding reproductive rights. Health Unchained is one of the Top 100 Healthcare Technology Podcasts on the web - Check us out on Feedspot (https://podcast.feedspot.com/healthcare_technology_podcasts/) Timestamps 00:00 Intro 01:30 Meet Anna Hall: Founder and CEO of Embody Space 01:51 The Importance of Data Privacy in Women's Health 03:50 Challenges and Solutions in Menstrual Health Tracking 05:09 Privacy Concerns and Legal Implications 07:50 Embody's Technology and Business Model 17:14 Future Plans and Collaborations 24:41 Final Thoughts and How to Connect Guest Links Embody website LinkedIn Mentioned resources The 19th Ep. 104: Laura Minquini (AthenaDAO founder) Health Unchained Links Supercast – Sign up to access premium content Website Telegram LinkedIn X

Meet Casper Barnes, co-founder and CEO of AminoChain, discusses the intersection of biobanking and blockchain technology. Barnes, who has a background in economics, neuroscience, and biotech, shares insights on decentralized science (DeSci) and how his company aims to revolutionize the use of biosamples in preclinical research. They delve into the importance of transparency and patient consent, and how blockchain can address these issues. Barnes also talks about AminoChain's partnerships, tech stack, challenges, funding, and future goals. The podcast highlights the ethical implications, potential for increased research efficiency, and the importance of building trust in the healthcare system through technology. Health Unchained is one of the Top 100 Healthcare Technology Podcasts on the web - Check us out on Feedspot (https://podcast.feedspot.com/healthcare_technology_podcasts/) Timestamps 00:00 Meet Casper Barnes: Journey and Background 01:43 Understanding Decentralized Science (DeSci) 02:48 The Importance of Biobanking and Blockchain 03:33 Casper's Personal Story and Inspiration 06:27 Challenges in Biobanking and Consent Rates 09:57 AminoChain's Vision and Technology 15:42 Current Network and Recent Funding 22:42 Advice for Startups in the DeSci Space 24:24 Partnerships and Future Plans 26:30 Distributed Node Architecture and NFT Marketplace 27:51 Choosing the Right Blockchain: Polygon to Optimism 29:26 Future Collaborations and Industry Criticisms 30:39 Tokenization Concepts and Patent Law 39:30 Privacy Compliance and De-Identification Challenges 43:54 Long-Term Goals and Impact on Biomedical Research 46:18 Outlook for 2025 and Regulatory Changes 49:42 Personal Insights: Books and Physical Activity 50:53 Closing Remarks and Contact Information Key quote 'We want to build an entirely new on-chain bio economy... where patients can benefit directly from scientific research using their samples.' Guest Links LinkedIn Aminochain website Mentioned resources Ep. 108 - Jelani Clark The Hard Thing About Hard Things: Building a Business When There Are No Easy Answers by Ben Horowitz Health Unchained Links Supercast – Sign up to access premium content Website Telegram LinkedIn X

Summary Barry Weber, the Chief Information Security Officer and Data Protection Officer at Global Genes brings decades of expertise in data compliance and cybersecurity.  The discussion centers on the importance of data privacy, the challenges of protecting sensitive health information, and the complexity of compliance with various privacy laws like GDPR, HIPAA, CCPA/CPRA, and state-specific regulations. Barry shares his experiences working across multiple industries, including his role in healthcare research focused on rare diseases. The conversation also explores the future of genetic data, the potential of blockchain technology in healthcare, and the evolving landscape of cybersecurity threats and AI's impact. Barry emphasizes the need for data minimization, careful management of identifiable information, and the importance of educating individuals about data protection. His leadership has been pivotal in implementing a comprehensive privacy and data security program that both aligns with IRB oversight and multinational privacy laws. Their team's approach, rooted in GDPR with extensions for US privacy laws, has been crucial in addressing the unique challenges faced by non-profits focused on rare diseases. Their governance model successfully integrates the nuanced requirements of legislation like WA MHMD and Nevada SB 370, setting a new standard in data protection and privacy. Timestamps 00:00 Introduction and Welcome 01:02 Meet Barry Weber: Data Privacy Expert  03:05 The Importance of Data Privacy 04:36 Privacy Frameworks and Compliance 07:57 Genetic Information and Privacy Laws 15:29 Global Genes and Rare Disease Research 21:46 Challenges in Data Protection and Sharing 33:49 The Role of AI and Blockchain in Cybersecurity 38:32 Personal Data Privacy Tips and Final Thoughts Guest Links LinkedIn Global Genes Mentioned resources GINA Act BeginNGS Program Cybersecurity with Sentinel One Health Unchained Links Supercast – Sign up to access premium content Website Telegram LinkedIn X

Arun Nadarasa on Social Prescribing and Blockchain in Pharmacy In this episode of Health Unchained, host Ray welcomes Arun Nadarasa, a pioneering pharmacist and founder of the International Social Prescribing Pharmacy Association. Arun talks about his journey in integrating social prescribing into community pharmacy and his insights on combining this with blockchain technology. He shares his experiences and challenges in promoting holistic patient care, including the launch of the Movement Pharmacy Association and his book 'Pharmacy Movement: How to Prescribe Social and Digital Medicines.' The discussion delves into the role of technology in healthcare, the potential of blockchain, and the significance of social determinants of health. Arun also discusses his passion for dance, particularly Krump for Parkinson's, and offers advice for healthcare professionals interested in social prescribing. He concludes with reflections on perseverance and growth, highlighting 'Think and Grow Rich' as an influential book in his journey. Timestamps 00:00 Arun Natarasa's Background and Journey into Pharmacy 03:18 Discovering Blockchain and Pharmacy Blockchain 05:59 Understanding Social Prescribing 10:21 Founding the International Social Prescribing Pharmacy Association 14:07 Arun's Passion for Dance 18:37 Challenges and Successes in Promoting Social Prescribing 25:46 The Role of Technology in Social Prescribing 35:34 Advice for Healthcare Professionals Interested in Social Prescribing 37:26 Final Thoughts and Book Recommendation (Think and Grow Rich by Napoleon Hill) Guest Links LinkedIn X ISPPA website - https://socialprescribing.health/ Mentioned resources https://socialprescribingusa.com/ https://pharmacyblockchainltd.com/ https://www.artpharmacy.co/ https://markmorrisdancegroup.org/ https://www.linkedin.com/company/global-social-prescribing-alliance/about/ Denise Silber - https://www.linkedin.com/in/denisesilber Dr. Xavier Schneider - https://www.linkedin.com/in/xavier-schneider-84a17311a/ https://healthunchained.org/ep-3-improved-access-to-medical-records-dr-abdullah-abeyatti-ceo-medicalchain/